- Home
- AWK vs MRNA Comparison
AWK vs MRNA Comparison
Compare AWK & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AWK | MRNA |
|---|---|---|
| Founded | 1886 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5B | 26.7B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AWK | MRNA |
|---|---|---|
| Price | $138.31 | $137.95 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 12 |
| Target Price | ★ $138.27 | $34.27 |
| AVG Volume (30 Days) | 2.2M | ★ 25.3M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | 5.57 | ★ 21.77 |
| EPS | ★ 2.61 | N/A |
| Revenue | $3,011,328,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $6.09 | $9.36 |
| Revenue Next Year | $6.90 | $15.43 |
| P/E Ratio | $52.37 | ★ N/A |
| Revenue Growth | 3.77 | ★ 4.29 |
| 52 Week Low | $120.57 | $22.28 |
| 52 Week High | $145.64 | $176.66 |
Technical Indicators
Market Signals| Indicator | AWK | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 63.84 |
| Support Level | $127.89 | $41.01 |
| Resistance Level | $139.63 | $176.66 |
| Average True Range (ATR) | 2.54 | 13.95 |
| MACD | -0.07 | 5.94 |
| Stochastic Oscillator | 58.53 | 67.07 |
Price Performance
Historical ComparisonAbout AWK American Water Works Company Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving nearly 4 million customers in 14 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns. The proposed Essential Utilities acquisition would add regulated water and wastewater utilities in Ohio, North Carolina, and Texas while increasing its presence in Illinois, Indiana, Pennsylvania, New Jersey, and Virginia.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.